John Hickenlooper (D-CO)· Aug 6, 2026
S.Amdt. 6751: In the nature of a substitute.
Adopted
With no one objecting, no names recorded
A Democratic bill with 3 Republican cosponsors · See all 9 cosponsors
Last activity — Held at the desk.
Passed one chamber, waiting for the other to take it up
Passed one chamber, and the other has not yet sent it to a committee or put it on its calendar.
The other chamber will hand it to a committee, place it on its calendar, or leave it where it is. Nothing has been decided, and a bill can sit here indefinitely.
Its path through Congress
The Senate by voice vote (members called out yes or no together): no senator's position on it was recorded.
The DeOndra Dixon INCLUDE Project Act of 2026 aims to amend the Public Health Service Act. It authorizes the Secretary of Health and Human Services to establish a specific program directed by the NIH. This program, known as the INCLUDE Project, focuses on research, training, and investigation related to Down syndrome. The initiative includes studying the effects of trisomy 21 and co-occurring conditions across the lifespan. It also emphasizes expanding clinical trials and improving quality of life for individuals and their families. Finally, the Act requires biennial reports to be submitted to specific Congressional committees.
Would people with disabilities be better off under this?
The bill provides significant benefits through research and clinical trial expansion for individuals with Down syndrome.
Does this put more money into medical research?
The act authorizes specific NIH research and training related to Down syndrome and co-occurring conditions.
Does this expand the rights of people with disabilities?
The bill promotes the needs of people with Down syndrome through specialized research and stakeholder consultation.
No question was scored the opposite.
Research on human development and health: The program includes high-risk, high-reward research on how trisomy 21 affects development, which could lead to better health outcomes (Section 2(b)(1)).
Improved understanding of co-occurring conditions: Through cohort studies, the program seeks to better understand Down syndrome alongside other conditions and develop new interventions (Section 2(b)(2)).
Expanded clinical trial access: The bill expands the number of clinical trials for participants with Down syndrome, including those testing new biomedical and pharmacological therapies to enhance daily living (Section 2(b)(3)).
Better diagnosis and treatment: Research into biological mechanisms and biomarkers aims to improve how conditions co-occurring with Down syndrome are diagnosed and treated (Section 2(b)(4) and Section 2(b)(5)).
Focus on specific health risks: The program targets research into the causes and treatments of increased prevalence of conditions like Alzheimer's disease, related dementias, and autoimmunity (Section 2(b)(6)).
Improved quality of life: The initiative includes investigation specifically aimed at improving the quality of life for individuals with Down syndrome and their families (Section 2(b)(7)).
Stakeholder inclusion: The Director of NIH is directed to consult with relevant stakeholders and patient advocates to ensure the needs of individuals with Down syndrome are considered (Section 2(d)).
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
John Hickenlooper (D-CO)· Aug 6, 2026
Adopted
With no one objecting, no names recorded
3 bills Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Democrat · Colorado
Democrat · New Jersey
Republican · West Virginia
Democrat · Delaware
Republican · Kansas
Republican · Oklahoma
Democrat · Georgia
Democrat · California
Democrat · Maryland